PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Southampton Clinical Trials Unit, University of Southampton, Southampton, Hampshire, UK. G.O.Griffiths@soton.ac.uk.\', \'NIHR Royal Liverpool and Broadgreen CRF, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.\', \'Lancaster University, Lancaster UK and MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.\', \'Southampton Clinical Trials Unit, University of Southampton, Southampton, Hampshire, UK.\', \'University of Liverpool, Liverpool, UK.\', \'Liverpool School of Tropical Medicine, Liverpool, UK.\', \'Royal Free London NHS Foundation Trust, London, UK.\', \'University of the Witwatersrand, Johannesburg, South Africa.\', \'Infectious Diseases Institute, Makerere University, Kampala, Uganda.\', \'Desmond Tutu Health Foundation, University of Cape Town, Cape Town, South Africa.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05458-4
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34311777
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34311777>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34311777>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all